A study showed Cabometyx improved time before disease progression in advanced digestive NETs compared with placebo.

Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.

Three-fourths of patients with unresectable gastroesophageal cancer converted to resectable and had clear margins after ...

Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, ...

Multidisciplinary care is needed to ensure positive maternal and fetal health outcomes, especially in complex or high-risk ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Drinking alcohol can irritate the intestinal tract and speed up digestion, increasing your risk of diarrhea. Here’s why and ...

Vancouver resident Peter Bracchi raises concerns over the city’s handling of homelessness, citing sanitation, crime, and ...

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...